Long term treatment of schizophrenia with Risperidone: An international, multicenter, open label trial. Ris-Int-36

New Trends in Experimental and Clinical Psychiatry

Volumn 14, Issue 4, 1998, Pages 165-171

  Karavias, G A ^a  

^a Athalassa Hospital   (Cyprus)

Author keywords

Negative symptoms; Positive symptoms; Risperidone; Role of 5HT2 receptors; Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOPAMINERGIC SYSTEM; DRUG EFFICACY; DRUG RECEPTOR BINDING; HUMAN; MALE; MENTAL DISEASE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0032411609     PISSN: 03935310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)